HKSTP showcases Hong Kong's Innovation and Technology edge

Hong Kong Science and Technology Parks Corporation (HKSTP) announced its fruitful participation in promoting Hong K...

November 2, 2018 | Friday | News
Kissei buys exclusive rights of Tavalisse in Asian countries

Japanese drugmaker Kissei Pharmaceutical has acquired exclusive rights to develop and commercialize Tavalisse (fostamati...

November 1, 2018 | Thursday | News
Green Science Alliance starts production of Chitin, Chitosan Nanofiber

Chitin nanofiber is a new material made from crab shells. In brief, it can be prepared by making chitin on a nanoscale. ...

October 30, 2018 | Tuesday | News
Mitsui Chemicals, Chitose Group launch novel open innovation initiative

Mitsui Chemicals, Inc. and Chitose Group, a group of biotechnology startups have jointly launched the "0 to 1 Project" a...

October 30, 2018 | Tuesday | News
NEC, Transgene collaborate for individualized cancer immunotherapy

NEC Corporation and Transgene have announced the signing of a Memorandum of Understanding (MoU) for a strategic collabor...

October 30, 2018 | Tuesday | News
Daiichi enters clinical collaboration with Merck, Pfizer

Daiichi Sankyo Company, Limited announced that it has entered into a clinical trial collaboration agreement with Merck K...

October 27, 2018 | Saturday | News
Mesoblast licensee seeks expanded indication for stem cell product in Japan

Singapore –  Mesoblast announces that Japanese licensee JCR Pharmaceuticals Co. Ltd. plans to seek a new...

October 24, 2018 | Wednesday | News
J & J announces Offer to Acquire Ci:z Holdings Co., Ltd.

Johnson & Johnson has announced that they have agreed with Ci:z Holdings Co., Ltd. a Japanese company focused on the...

October 23, 2018 | Tuesday | News
Eisai, MSD start marketing activity for LENVIMA

Eisai Co., Ltd. and MSD K.K., a subsidiary of Merck & Co., Inc., Kenilworth, N.J., U.S.A., have announced that the t...

October 23, 2018 | Tuesday | News
Anaeropharma, Chugai come together to create Novel Oncology Drugs

Anaeropharma Science and Chugai Pharmaceutical Co., Ltd. headquartered in Tokyo have concluded a collaborative rese...

October 22, 2018 | Monday | News
Eisai discovers new compound to treat Parkinson's disease

A joint research group centered around Professor Hideyuki Okano and Associate Professor Jun Kohyama, Department of Physi...

October 19, 2018 | Friday | News
Daiichi Sankyo submits NDA in Japan for leukemia drug

Daiichi Sankyo Company,  recently announced that it has submitted a New Drug Application (NDA) to Japan’s Min...

October 17, 2018 | Wednesday | News
Eisai, Purdue Pharma declare positive results of SUNRISE 2

Eisai Co., Ltd. and Purdue Pharma L.P. announced positive topline results from SUNRISE 2, a long-term Phase 3 efficacy a...

October 17, 2018 | Wednesday | News
Eisai signs pact with Eurofarma for anti-obesity agent

Eisai Co., Ltd. has entered into an agreement with Eurofarma Laboratorios, to grant exclusive development and marketing ...

October 16, 2018 | Tuesday | News
Hitachi's heavy ion beam therapy system starts treatment at Osaka

Hitachi, Ltd. announced that its heavy ion beam therapy system has started treatment at Osaka Heavy Ion Therapy Center a...

October 16, 2018 | Tuesday | News
Innovus Pharma receives approval from Amazon for expansion in Japan

Innovus Pharmaceuticals, an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effectiv...

October 15, 2018 | Monday | News
GHIT Fund partners with Ono Pharmaceutical

The Global Health Innovative Technology (GHIT) Fund has welcomed Ono Pharmaceutical Co., Ltd. (Ono) to join GHIT as a ne...

October 15, 2018 | Monday | News
Scientists develop in vivo skin imaging technology

A team of scientists from Tohoku University in collaboration with Advantest has developed in vivo skin imaging technolog...

October 13, 2018 | Saturday | News